Loss of expression of pan B‐cell antigens, such as CD20, has been used to argue for a diagnosis of B‐ALL/LBL, while the expression of mature B‐cell antigens such as BCL6 and MUM1 favours the diagnosis of mature rather than precursor B‐cell lymphoma. This evidence concerns the gene BCL6 and acute lymphoblastic leukemia.